Ipamorelin

Source / Derivation:

Ipamorelin is a synthetic pentapeptide derived from selective ghrelin receptor agonist research, developed to stimulate growth hormone release with exceptional receptor specificity and minimal hormonal spillover.

Ipamorelin

Mechanism of Action:

Ipamorelin activates ghrelin (GHSR) receptors in the pituitary and hypothalamus, triggering controlled GH secretion without significantly affecting cortisol, prolactin, or appetite pathways. This targeted signaling supports repair, recovery, and anabolic processes while maintaining physiologic balance.

Clinical Relevance & Potential Outcomes:

Evidence suggests Ipamorelin may enhance tissue repair, lean mass development, fat metabolism, sleep quality, and overall recovery capacity. Its clean pharmacologic profile makes it a preferred option for precision GH modulation.

Intended Clinical Application:

Ipamorelin may be relevant for patients needing gentle yet effective GH stimulation to support healing, body composition, restorative sleep, or general recovery.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

5 mg/ml, total 3 ml, total 15 mg

Daily

1 month

A selective growth hormone secretagogue that stimulates GH release without increasing cortisol or prolactin, supporting muscle growth and recovery.